ArticleCellular and molecular life sciences : CMLS2026
PPARa-FSP1 axis modulates lipid peroxidation-induced neuronal ferroptosis to promote functional recovery in mouse model of traumatic spinal cord injury.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Bilirubin and the Yellow Players in Ferroptosis: A Delicate Balance in Human Health and Disease, with a Focus on the Liver, Cardiovascular System, and Brain.Biomolecules · 2026Review
- Advances in ferroptosis and cuproptosis: implications for spinal cord injury.Molecular biology reports · 2026Review
Corrections and comments
- Erratum issued
Authors and funding
9 authors.
Funding
Abstract
Prior studies have shown that inhibiting ferroptosis could facilitate neural repair following traumatic spinal cord injury (TSCI), yet the underlying mechanisms remain unclear. In this study, we first demonstrated that ferroptosis occurred locally at the injury site of TSCI, and was closely associated with lipid metabolism and the PPARa signaling pathway. Notably, we observed a significant decrease in PPARa expression in neurons during the early stage of TSCI, and modulating PPARa activity influences lipid peroxidation-induced ferroptosis, which was linked to preservation of motor function. Mechanistically, we identified PPARa as a transcriptional activator of FSP1, which subsequently activated the CoQ10-NAD(P)H antioxidant system to inhibit ferroptosis through a GPX4-independent pathway. Furthermore, we found that the distribution of FSP1 in the spinal cord mirrored that of PPARa, with high expression in neurons and a notable decline during the early stages of TSCI. Finally, we confirmed that the PPARa-FSP1 pathway modulated neuronal responses to lipid peroxidation-induced ferroptosis following TSCI, promoting functional recovery. In conclusion, our findings highlighted that PPARa promoted TSCI recovery by suppressing lipid peroxidation-induced neuronal ferroptosis via the FSP1 pathway, and positioned the PPARa-FSP1 axis as a central mechanism in post-TSCI ferroptosis and a promising therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.